Xometry, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Loss (In thousands, except share and per share amounts) (Unaudited) | |||||||
Three Months Ended
March 31, | |||||||
2024 | 2023 | ||||||
Revenue | $ | 122,690 | $ | 105,326 | |||
Cost of revenue | 74,788 | 65,957 | |||||
Gross profit | 47,902 | 39,369 | |||||
Sales and marketing | 27,200 | 22,439 | |||||
Operations and support | 14,047 | 12,608 | |||||
Product development | 9,590 | 8,125 | |||||
General and administrative | 14,922 | 15,957 | |||||
Impairment of assets | - | 27 | |||||
Total operating expenses | 65,759 | 59,156 | |||||
Loss from operations | (17,857 | ) | (19,787 | ) | |||
Other income (expenses) | |||||||
Interest expense | (1,189 | ) | (1,198 | ) | |||
Interest and dividend income | 2,732 | 2,695 | |||||
Other (expenses) income | (387 | ) | 17 | ||||
Income from unconsolidated joint venture | 97 | 66 | |||||
Total other income | 1,253 | 1,580 | |||||
Loss before income taxes | (16,604 | ) | (18,207 | ) | |||
Provision for income taxes | - | (136 | ) | ||||
Net loss | (16,604 | ) | (18,343 | ) | |||
Net income attributable to noncontrolling interest | 12 | 1 | |||||
Net loss attributable to common stockholders | $ | (16,616 | ) | $ | (18,344 | ) | |
Net loss per share, basic and diluted, of Class A and Class B common
stock | $ | (0.34 | ) | $ | (0.38 | ) | |
Weighted-average number of shares outstanding used to compute
net loss per share, basic and diluted, of Class A and Class B common stock | 48,577,980 | 47,699,561 | |||||
Net loss | $ | (16,604 | ) | $ | (18,343 | ) | |
Comprehensive loss: | |||||||
Foreign currency translation | (457 | ) | 135 | ||||
Total other comprehensive (loss) income | (457 | ) | 135 | ||||
Comprehensive loss | (17,061 | ) | (18,208 | ) | |||
Comprehensive income attributable to noncontrolling interest | 29 | 5 | |||||
Total comprehensive loss attributable to common stockholders | $ | (17,090 | ) | $ | (18,213 | ) | |